Optiray 300 636 mg/mL

Optiray 300 636 mg/mL is a radiopaque contrast agent used for diagnostic imaging procedures. This injection, manufactured by Liebel-Flarsheim Company LLC, aids in enhancing visibility during imaging studies.

Optiray 300 636 mg/mL is primarily used as a contrast medium to improve the clarity of images during X-ray, CT scans, and other imaging techniques. It is administered intravenously or intra-arterially to help healthcare professionals visualize blood vessels, organs, and tissues more clearly. This can be particularly useful in identifying abnormalities or blockages.

Common effects of Optiray 300 636 mg/mL may include a warm sensation or a metallic taste in the mouth during administration. Some individuals might experience mild discomfort at the injection site. These effects are generally temporary and subside quickly.

Optiray 300 636 mg/mL should be used with caution in individuals with known allergies to iodine or other contrast agents. It is important to inform healthcare professionals about any existing medical conditions or allergies before administration. Proper handling and storage are essential to maintain the integrity of the product.

Optiray 300 636 mg/mL may interact with certain medications or substances. It is advisable to consult with a healthcare professional regarding potential interactions, especially with other contrast agents or medications that affect kidney function. Alcohol and certain foods may also influence the effectiveness or safety of the contrast agent.